See also this year's filing and all EDGAR filings for this company.
PDF Report 0000744218_2023_Celldex_Therapeutics_Inc.pdf
Logs
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0000744218, Celldex Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 7,921,000 |
| 1 | LiabilitiesCurrent | 18,610,000 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 317,693,000 |
| 4 | AssetsNoncurrent | 4,105,000 |
| 5 | PropertyPlantAndEquipmentNet | 3,747,000 |
| 6 | Goodwill | 27,190,000 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 27,195,000 |
| 9 | ResearchAndDevelopmentExpense | 82,258,000 |
| 10 | remainder_Expenses | 8,138,000 |
| 11 | remainder_Revenues | 5,266,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -634,000 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 26,531,000 |
| 1 | Assets | 352,735,000 |
| 2 | Expenses | 117,591,000 |
| 3 | Revenues | 5,266,000 |
| 4 | StockholdersEquity | 326,204,000 |
| 5 | NetIncome | -112,325,000 |
| 6 | ComprehensiveNetIncome | -112,642,000 |
| 7 | BaseVar | 251,378,500 |
| 8 | EconomicCapitalRatio | 0.868 |
Edgar->Model Mapping
Feature Distribution
Change over Time
